Biotechnology - , Kansas, United States
Cognizance Biomarkers, LLC, a molecular diagnostics company, is proposing a revolutionary shift in the diagnosis of epileptic seizures that will allow for rapid stratification and identification of patients, yielding improved patient outcomes and significant cost savings to the healthcare system.
Outlook
Apache
WordPress.org
Google Font API
Mobile Friendly